OBJECTIVES: Granulomatosis with polyangiitis (GPA) is a relapsing small-vessel vasculitis characterized by circulating ANCA against PR3. The mechanisms that trigger PR3-ANCA production are unknown. The aim of this study was to determine whether endogenous factors [B cell activating factor (BAFF) and IL-21] and exogenous factors [oligodeoxynucleotides containing CpG motifs (CpG-ODN)] synergize in stimulating PR3-ANCA production in GPA patients. METHODS: Peripheral blood mononuclear cells from GPA patients and healthy controls (HCs) were cultured in the presence of BAFF and IL-21, with or without CpG-ODN, for 12 days. PR3-ANCA production in culture supernatants was quantified by Phadia EliA. Phenotypic characterization and the influence of CpG-ODN treatment on IL-21 receptor (IL-21R), transmembrane activator and calcium-modulator and cyclophilin ligand interactor (TACI) and BAFF receptor (BAFF-R) expression on B cells was analysed by flow cytometry. RESULTS: Stimulation with BAFF and IL-21 significantly increased ANCA production in patient samples, which could be augmented further by addition of CpG-ODN. Stimulation with CpG-ODN increased the percentage of IL-21R(+) and TACI(+) B cells but did not affect BAFF-R expression. GPA patients had an increased percentage of circulating IL-21R(+) and a decreased percentage of TACI(+) circulating memory B cells when compared with HCs. Additionally, patients had decreased expression of BAFF-R on B cells, which was inversely correlated with BAFF concentrations in plasma. CONCLUSION: Our data demonstrate that endogenous and exogenous factors can synergize to promote PR3-ANCA production. Mechanistically, CpG-ODN up-regulated IL-21R and TACI expression on B cells, possibly sensitizing these cells for IL-21- and BAFF-mediated signals. Agents inhibiting Toll-like receptor 9, BAFF and IL-21 signalling pathways may serve as potential therapeutics for intervention in GPA patients.
OBJECTIVES:Granulomatosis with polyangiitis (GPA) is a relapsing small-vessel vasculitis characterized by circulating ANCA against PR3. The mechanisms that trigger PR3-ANCA production are unknown. The aim of this study was to determine whether endogenous factors [B cell activating factor (BAFF) and IL-21] and exogenous factors [oligodeoxynucleotides containing CpG motifs (CpG-ODN)] synergize in stimulating PR3-ANCA production in GPA patients. METHODS: Peripheral blood mononuclear cells from GPA patients and healthy controls (HCs) were cultured in the presence of BAFF and IL-21, with or without CpG-ODN, for 12 days. PR3-ANCA production in culture supernatants was quantified by Phadia EliA. Phenotypic characterization and the influence of CpG-ODN treatment on IL-21 receptor (IL-21R), transmembrane activator and calcium-modulator and cyclophilin ligand interactor (TACI) and BAFF receptor (BAFF-R) expression on B cells was analysed by flow cytometry. RESULTS: Stimulation with BAFF and IL-21 significantly increased ANCA production in patient samples, which could be augmented further by addition of CpG-ODN. Stimulation with CpG-ODN increased the percentage of IL-21R(+) and TACI(+) B cells but did not affect BAFF-R expression. GPA patients had an increased percentage of circulating IL-21R(+) and a decreased percentage of TACI(+) circulating memory B cells when compared with HCs. Additionally, patients had decreased expression of BAFF-R on B cells, which was inversely correlated with BAFF concentrations in plasma. CONCLUSION: Our data demonstrate that endogenous and exogenous factors can synergize to promote PR3-ANCA production. Mechanistically, CpG-ODN up-regulated IL-21R and TACI expression on B cells, possibly sensitizing these cells for IL-21- and BAFF-mediated signals. Agents inhibiting Toll-like receptor 9, BAFF and IL-21 signalling pathways may serve as potential therapeutics for intervention in GPA patients.
Authors: Casper Marsman; Dorit Verhoeven; Jana Koers; Theo Rispens; Anja Ten Brinke; S Marieke van Ham; Taco W Kuijpers Journal: Front Immunol Date: 2022-06-29 Impact factor: 8.786
Authors: Alvise Berti; Roscoe Warner; Kent Johnson; Divi Cornec; Darrell Schroeder; Brian Kabat; Carol A Langford; Gary S Hoffman; Fernanado C Fervenza; Cees G M Kallenberg; Philip Seo; Robert Spiera; E William St Clair; Paul Brunetta; John H Stone; Peter A Merkel; Ulrich Specks; Paul A Monach Journal: Arthritis Rheumatol Date: 2018-05-07 Impact factor: 10.995
Authors: Judith Land; Wayel H Abdulahad; Suzanne Arends; Jan-Stephan F Sanders; Coen A Stegeman; Peter Heeringa; Abraham Rutgers Journal: PLoS One Date: 2017-08-03 Impact factor: 3.240
Authors: Anouk von Borstel; Judith Land; Wayel H Abdulahad; Abraham Rutgers; Coen A Stegeman; Arjan Diepstra; Peter Heeringa; Jan Stephan Sanders Journal: Front Immunol Date: 2019-09-24 Impact factor: 7.561
Authors: Anouk von Borstel; Wayel H Abdulahad; Jan Stephan Sanders; Jasper Rip; Stefan F H Neys; Rudi W Hendriks; Coen A Stegeman; Peter Heeringa; Abraham Rutgers; Odilia B J Corneth Journal: Rheumatology (Oxford) Date: 2019-12-01 Impact factor: 7.580
Authors: Judith Land; Lucas L Lintermans; Coen A Stegeman; Ernesto J Muñoz-Elías; Eric J Tarcha; Shawn P Iadonato; Peter Heeringa; Abraham Rutgers; Wayel H Abdulahad Journal: Front Immunol Date: 2017-09-26 Impact factor: 7.561